136 results on '"Van Den Hoogen, F."'
Search Results
2. Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
3. POS0078 COMPARING METHOTREXATE MONOTHERAPY WITH METHOTREXATE PLUS LEFLUNOMIDE COMBINATION THERAPY IN PSORIATIC ARTHRITIS: A RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL (COMPLETE-PsA)
4. POS0652 LONG-TERM EFFECTIVENESS OF ULTRA-LOW DOSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS
5. OP0261 TREAT-TO-TARGET DOSE REDUCTION AND WITHDRAWAL STRATEGY OF TNF INHIBITORS IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL
6. POS0646 NON-MEDICAL SWITCHING FROM TOCILIZUMAB TO SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY
7. Oorsuizen
8. POS0343 RITUXIMAB IS SUPERIOR TO PLACEBO IN POLYMYALGIA RHEUMATICA
9. POS0193 DAS28-CRP GUIDED TREAT-TO-TARGET TAPERING OF TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS: A RETROSPECTIVE COHORT STUDY.
10. Use and usability of the Dr. Bart app and its relation with health care utilization and clinical outcomes in people with knee and/or hip osteoarthritis
11. Economic evaluation of the Dr. Bart app in people with knee and/or hip osteoarthritis
12. THU0412 EFFECT OF METFORMIN ON CLINICAL GOUT OUTCOMES IN GOUT PATIENTS WITH DIABETES MELLITUS
13. FRI0209 EFFECTS OF ADD-ON METHOTREXATE IN POLYMYALGIA RHEUMATICA PATIENTS: A RETROSPECTIVE STUDY
14. FRI0629-HPR USE AND USABILITY OF THE DR. BART APP AND ITS RELATION WITH CLINICAL OUTCOMES IN PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS
15. AB0505 SEASONAL INFLUENCE IN PMR: NOT ONLY SUMMER, BUT WINTER IS COMING TOO
16. AB0582 DIAGNOSING SYSTEMIC SCLEROSIS WITH PHOTOACOUSTIC AND HIGH-FREQUENCY ULTRASOUND IMAGING
17. OP0072 IDENTIFYING POLYMYALGIA RHEUMATICA RELAPSE AND ITS ASSOCIATIONS IN A RETROSPECTIVE COHORT
18. OP0155-HPR EFFECT OF THE DR. BART APPLICATION ON HEALTHCARE USE AND CLINICAL OUTCOMES IN PEOPLE WITH OSTEOARTHRITIS OF THE KNEE AND / OR HIP IN THE NETHERLANDS; A RANDOMIZED CONTROLLED TRIAL
19. AB1314-HPR ECONOMIC EVALUATION OF THE DR. BART APP IN PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS
20. THU0448 NO DIFFERENCE IN GOUT FLARES AFTER INITIATION OF URATE LOWERING THERAPY BETWEEN ONCE OR TWICE DAILY 0.5 MG COLCHICINE PROPHYLAXIS
21. TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?
22. Oorsuizen
23. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
24. AB0053 A bioassay to measure tgfΒ activity reveals decreased tgfΒ activity in ssc serum
25. OP0058 Low-dose radiation therapy as treatment for hand and knee osteoarthritis: two double-blinded rct’s
26. AB1034 The urate-lowering effect of febuxostat 80 mg and 40 mg (80 MG FILM-COATED TABLETS SPLIT IN HALF) in gout patients in daily clinical practice
27. SAT0485 What is the effect of cyclophosphamide iv pulse therapy in patients with diffuse cutaneous systemic sclerosis on skin involvement: an observational study
28. FRI0437 Is extended auto antibody profiling associated with the prevalence of disease complications?
29. AB0776 Muscle ultrasonography: a potential new diagnostic tool for inflammatory myopathies
30. FRI0551 Comparison of physical activity (PA) between patients with different stages of osteoarthritis(OA) and the general population: a cross-sectional study
31. SAT0191 The patient perspective on bdmard dose reduction: a mixed methods study
32. P076 A bioassay to measure tgfΒ activity reveals decreased tgfΒ activity in systemic sclerosis serum
33. Drooling Infants and Preschoolers Scale
34. There is a need for new systemic sclerosis subset criteria. A content analytic approach
35. Identification of synovial expression patterns that are associated with pain and progression of joint damage in early osteoarthritis
36. THU0645-HPR Perceived Barriers and Facilitators for bDMARD Dose Optimization: A Qualitative Study into Ra Patients' Perspectives
37. THU0142 High Similarity between ex-vivo Inhibited Cytokine Profiling by Golimumab and Adalimumab as A Putative Explanation for Inferior Treatment Response To Golimumab after Adalimumab Failure in Rheumatoid Arthritis
38. OP0028 Association of Differential Synovial Expression Patterns in Early Osteoarthritis with Pain and Progression of Joint Damage
39. THU0058 Prediction of Successful Dose Reduction or Discontinuation of Biologics in Patients with Rheumatoid Arthritis: A Systematic Review
40. Frequently asked questions of patients with osteoarthritis: a consensus exercise
41. Controlling the Cost Spent on Expensive Biologic Agents: an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients
42. AB0247 Associations of a Multi-Biomarker Disease Activity Score with Clinical and Radiographic Parameters in Rheumatoid Arthritis
43. THU0011 Early Osteoarthritis Patients with Progression of Cartilage Damage or Osteophyte Formation Show Different Synovial Expression Patterns
44. AB0246 Predictive Value of a Multi-Biomarker Disease Activity Score for Successful Dose Reduction of TNF Inhibitors in Rheumatoid Arthritis: Results of the Dress Study
45. AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach
46. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
47. THU0455 Transcriptomics to Identify Synovial Genes and Pathways Associated with Disease Progression in A Cohort of Early Osteoarthritis Patients (CHECK)
48. FRI0508 Type and Timing of First Symptoms in Systemic Sclerosis: Prediction of Disease Course: Table 1.
49. Identification of synovial genes and pathways associated with disease progression in a cohort of early osteoarthritis patients (check)
50. Response to: ‘Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?’ by Jan Damoiseaux
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.